Company intelligence / Profile preview

Formue Nord Fokus

Aalborg, North Denmark Region, Denmark

Ownership: Private
Development stage: Other

Overview

Formue Nord Fokus (now Fenja Capital II) is an actively managed Nordic investment fund focusing on long-term structured financing for listed growth companies, often helping extend financial runway for companies in need of capital, including some biotech clients. It rebranded to Fenja Capital II in 2024 under the broader Fenja Capital asset management umbrella.

Industry: Investors

Partnerships

Fenja Capital (parent/manager)Ascelia PharmaIRLAB TherapeuticsSaniona

Beyond the preview

Go deeper on Formue Nord Fokus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Formue Nord Fokus.

Explore the full profile